|

pCAD-POAF 3 Year Follow-up

RECRUITINGSponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
SponsorChina National Center for Cardiovascular Diseases
Started2025-08-15
Est. completion2027-01
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted

Summary

This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery. The primary outcome is the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery. The secondary outcomes are:the individual components of the primary composite outcome; unplanned all-cause rehospitalization; arrhythmias other than atrial fibrillation; premature atrial contraction and premature ventricular contraction burdens; heart rate variability parameters; quality-of-life scores; and other Holter-derived parameters.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* This study will include the subjects who enrolled in pCAD-POAF trial

Exclusion Criteria:

* This study will include the subjects who enrolled in pCAD-POAF trial

Conditions3

Atrial FibrillationCoronary Artery DiseaseHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.